Please assess the completion status of the following clinical trial:

Trial Title: Epidermal Grafting in Wound Healing

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Male or female~2. Age 18-90~3. Wound measuring more than 1cm x 1cm and lesser than 5cm x 5cm (1% TBSA)~4. Wound with clean, healthy granulating bed, with minimal adherent slough~5. Patient understands and is willing to participate and can comply with weekly visits and follow-up regime~Exclusion Criteria:~1. Wound with active infection~2. Wound at plantar of the foot~3. Patients unsuitable for Split Skin Grafting~4. Previous history of excessive bleeding associated with surgical biopsies or trauma~5. Allergies to tegaderm (and other dressings used in the study)~6. Known uncontrolled Diabetes Mellitus, as measured by an HbA1c \> 10%.~7. Presence of one or more medical conditions, including renal, hepatic, hematologic, active auto-immune or immune diseases that, would make the subject an inappropriate candidate for this ulcer healing study~8. Patient not fit for surgery (ASA classification \> 4)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: t

Study Arms:
- Epidermal Graft (Type: EXPERIMENTAL): The Cellutome Epidermal Graft Harvesting System will be used to harvest epidermal grafts as per existing normal clinical practice.
- Split Thickness Skin Graft (Type: EXPERIMENTAL): Split thickness skin graft will be harvested using air dermatome as per normal clinical practise.

Based on this trial design, predict the completion outcome and termination type (if applicable).